Cesarman E - Search Results

1

Rituximab does not improve clinical outcome in a randomized phase 3 trial of CHOP with or without rituximab in patients with HIV-associated non-Hodgkin lymphoma: AIDS-Malignancies Consortium Trial 010.

Kaplan LD, Lee JY, Ambinder RF, Sparano JA, Cesarman E, Chadburn A, Levine AM, Scadden DT. Kaplan LD, et al. Among authors: cesarman e. Blood. 2005 Sep 1;106(5):1538-43. doi: 10.1182/blood-2005-04-1437. Epub 2005 May 24. Blood. 2005. PMID: 15914552 Free PMC article. Clinical Trial.

2

Structural and functional analysis of oncogenes and tumor suppressor genes in adult T-cell leukemia/lymphoma shows frequent p53 mutations.

Cesarman E, Chadburn A, Inghirami G, Gaidano G, Knowles DM. Cesarman E, et al. Blood. 1992 Dec 15;80(12):3205-16. Blood. 1992. PMID: 1361372 Free article.

3

Correlative morphologic and molecular genetic analysis demonstrates three distinct categories of posttransplantation lymphoproliferative disorders.

Knowles DM, Cesarman E, Chadburn A, Frizzera G, Chen J, Rose EA, Michler RE. Knowles DM, et al. Among authors: cesarman e. Blood. 1995 Jan 15;85(2):552-65. Blood. 1995. PMID: 7812011 Free article.

4

Molecular characterization of CD30+ anaplastic large-cell lymphoma: high frequency of c-myc proto-oncogene activation.

Inghirami G, Macri L, Cesarman E, Chadburn A, Zhong J, Knowles DM. Inghirami G, et al. Among authors: cesarman e. Blood. 1994 Jun 15;83(12):3581-90. Blood. 1994. PMID: 8204884 Free article.

5

CD30 (Ki-1) positive anaplastic large cell lymphomas in individuals infected with the human immunodeficiency virus.

Chadburn A, Cesarman E, Jagirdar J, Subar M, Mir RN, Knowles DM. Chadburn A, et al. Among authors: cesarman e. Cancer. 1993 Nov 15;72(10):3078-90. doi: 10.1002/1097-0142(19931115)72:10<3078::aid-cncr2820721033>3.0.co;2-f. Cancer. 1993. PMID: 8221575

6

Primary effusion lymphoma: a distinct clinicopathologic entity associated with the Kaposi's sarcoma-associated herpes virus.

Nador RG, Cesarman E, Chadburn A, Dawson DB, Ansari MQ, Sald J, Knowles DM. Nador RG, et al. Among authors: cesarman e. Blood. 1996 Jul 15;88(2):645-56. Blood. 1996. PMID: 8695812 Free article.

7

Molecular pathology of posttransplantation lymphoproliferative disorders.

Chadburn A, Cesarman E, Knowles DM. Chadburn A, et al. Among authors: cesarman e. Semin Diagn Pathol. 1997 Feb;14(1):15-26. Semin Diagn Pathol. 1997. PMID: 9044506 Review.

8

Epstein-Barr virus latent gene expression in primary effusion lymphomas containing Kaposi's sarcoma-associated herpesvirus/human herpesvirus-8.

Horenstein MG, Nador RG, Chadburn A, Hyjek EM, Inghirami G, Knowles DM, Cesarman E. Horenstein MG, et al. Among authors: cesarman e. Blood. 1997 Aug 1;90(3):1186-91. Blood. 1997. PMID: 9242551 Free article.

9

BCL-6 gene mutations in posttransplantation lymphoproliferative disorders predict response to therapy and clinical outcome.

Cesarman E, Chadburn A, Liu YF, Migliazza A, Dalla-Favera R, Knowles DM. Cesarman E, et al. Blood. 1998 Oct 1;92(7):2294-302. Blood. 1998. PMID: 9746767 Free article.

10

Telomerase activity in B-cell non-Hodgkin lymphoma.

Ely SA, Chadburn A, Dayton CM, Cesarman E, Knowles DM. Ely SA, et al. Among authors: cesarman e. Cancer. 2000 Jul 15;89(2):445-52. doi: 10.1002/1097-0142(20000715)89:2<445::aid-cncr33>3.0.co;2-t. Cancer. 2000. PMID: 10918178

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

220 results

Search Page

Filters